Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-18-004024
Filing Date
2018-04-05
Accepted
2018-04-05 07:55:47
Documents
7
Period of Report
2018-05-15
Effectiveness Date
2018-04-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A cercdef14a-2018.htm DEF 14A 1142686
2 docs1024332v2cercdef1_image1.jpg GRAPHIC 14578
3 docs1024332v2cercdef1_image2.jpg GRAPHIC 21578
4 pxb20385a01001.jpg GRAPHIC 74973
5 pxf20385a02001.jpg GRAPHIC 178383
6 pxi20385a01001.jpg GRAPHIC 212079
7 pxn20385a01001.jpg GRAPHIC 203615
  Complete submission text file 0001628280-18-004024.txt   2103913
Mailing Address 400 E. PRATT ST. SUITE 606 BALTIMORE MD 21202
Business Address 400 E. PRATT ST. SUITE 606 BALTIMORE MD 21202 410-522-8707
Cerecor Inc. (Filer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37590 | Film No.: 18739334
SIC: 2834 Pharmaceutical Preparations